Schedule 13D ownership disclosure
TALARIS THERAPEUTICS INC
Security class unavailable · CUSIP: 87410C104
Event date: 2023-10-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-266288
- Form type
- SC 13D
- Filer
- Longitude Capital Partners III, LLC
- CIK
- CIK 1713663
- Filed
- Oct 30, 2023
- Reporting period
- Oct 19, 2023
- Description
- Schedule 13D beneficial ownership